Puma Biotechnology | PBYI - DEBITO





DEBITO Cambiamento Data
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amgen USD 57.32B 2.72B 2026-03
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Daiichi Sankyo JPY 300.48B 99.34B 2026-03
Exelixis USD 165.93M 3.61M 2026-06
Gilead Sciences USD 22.17B 2.76B 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Incyte USD 38.27M 1.16M 2026-06
MacroGenics USD 36.51M 500K 2026-03
Moderna USD 1.3B 7M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Takeda JPY 4.94T 58.13B 2026-06
TG Therapeutics USD 754.44M 884K 2026-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06